Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: March 2007
-
By Donald Zuhn On Monday, Canadian pharmaceutical company Biovail (NYSE: BVF) announced that it had reached a comprehensive settlement with Anchen Pharmaceuticals, Impax Laboratories, Teva Pharmaceutical Industries, and Watson Pharmaceuticals with respect to Wellbutrin XL® (bupropion HCl), a once-daily antidepressant which has a low incidence of sexual dysfunction, weight gain, and somnolence, and…
-
By Mark Chael Novartis announced today that the U.S. Food and Drug Administration approved the use of Tekturna® (aliskiren) for the treatment of high blood pressure as a single therapy or in combination with other high blood pressure medications. Apparently, the FDA had previously indicated that it would need more time to review…
-
By Mark Chael Eli Lilly and Co. (NYSE: LLY) announced today that it will acquire Hypnion, Inc. of Lexington, MA., a privately held CNS drug discovery company investigating sleep and wakefulness-alertness disorders as well as circadian rhythm abnormalities. Financial terms of the deal, which is expected to close in 2007, were not disclosed.…
-
By Sherri Oslick About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Abbott Laboratories v. ImClone Systems, Inc.1:07-cv-10216; filed February 5, 2007 in the District Court of Massachusetts Infringement of U.S. Patent No. 5,665,578 ("Vector…
-
March 21-22, 2007 – Complex IP & Technology Transactions Conference (Law Seminars International) – Chicago, IL March 25-29, 2007 – American Chemical Society National Meeting – Chicago, IL April 16-18, 2007 – Biotechnology: Patent Prosecution, Licensing, Litigation & Hatch-Waxman (Patent Resources Group) – Orlando, FL April 27, 2007 – Patent Claim Construction Workshop (Law Seminars…
-
By Donald Zuhn Last Monday, PricewaterhouseCoopers announced the release of its 2007 Patent and Trademark Damages Study. According to the study, while the number of patent infringement actions increased every year between 1991 and 2004, the number of filed patent cases dropped in 2005 – constituting the first decline in sixteen years. In…
-
By Donald Zuhn As noted by Patent Docs earlier this week, a recent article at BusinessWeek.com has issued a poor prognosis for biotech IPO’s. If the events of the past week are any indication, rumors of the "demise" of biotech IPO’s may have been greatly exaggerated. On Tuesday, Rosetta Genomics announced that its…
-
By Donald Zuhn Danisco A/S has announced that as a result of a finding of willful infringement by the District Court of Delaware, it would have to pay Novozymes A/S $8.2 million in damages, as well as a share of Novozymes’ legal fees. Patent Docs reported on the Novozymes case last month (Defendant…
Patent Docs 